Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Evaluation and Study of the Cost of Illness of Tuberculosis in Indonesia: A Systematic Review

Journal of Public Health and Pharmacy · Vol. 6 No. 1 (2025) · hlm. 49–65

DOI
10.56338/jphp.v6i1.6854
ISSN
2775-4952
Terbit
2025-12-05
Penerbit
Pusat Pengembangan Teknologi Informasi dan Jurnal Universitas Muhammadiyah Palu
Bahasa
eng

Abstrak

Introduction: Tuberculosis (TB) remains a significant public health challenge in Indonesia, ranking among the highest global TB burden countries. The financial burden of TB is substantial, encompassing direct medical costs, indirect income losses, and catastrophic household expenditures. Although systematic reviews on TB-related cost-of-illness (COI) have been conducted in various settings, this study aims to fill critical gaps in Indonesian TB financial data, provide comparative regional insights, and offer actionable policy recommendations. Methods: This study used the Systematic Review (SR) method on articles relevant to: COI, disease cost evaluation, or therapy costs for tuberculosis. Articles are examined in English or Indonesian; obtain full text through several search engines such as: PUBMED, Science Direct, Google Scholar, and SCOPUS; research coverage in Indonesia; and in an unlimited time frame. Results: A total of 11 eligible articles were obtained based on inclusion and exclusion criteria. The direct cost of TB-DS ranges from Rp2.2-5.8 million, while TB-MDR reaches Rp190 million. Indirect costs due to loss of revenue reached Rp481.5 million for MDR-TB. Catastrophic costs occurred in 83% of TB-MDR households and 36% of TB-DS, exceeding 20% of annual income. Most patients were men of productive age (18-45 years), with 82.33% losing their jobs during treatment. These findings highlight the need for strategic interventions to reduce the economic impact of TB. Conclusions: The impact of moderate financial burdens and other medical aspects on institutions and individuals is caused by tuberculosis. Further research should be conducted related to this study to obtain a larger estimate.

Kata kunci

Jaringan kolaborasi para penulis

11 penulis · 21 tautan kepenulisan bersama · 6 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Riza AlfianSekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin3
Umi AthiyahUniversitas Airlangga2
Ira PuspitasariUniversitas Airlangga1
Wahyuri WahyuriUniversitas Airlangga1
Rokayah RokayahUniversitas Airlangga1
Hanni Prihhastuti PuspitasariUniversitas Airlangga1
Abdul RahemUniversitas Airlangga1
Irma SusantiUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://jurnal.unismuhpalu.ac.id/index.php/jphp/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Evaluation and Study of the Cost of Illness of Tuberculosis in Indonesia: A Systematic Review</dc:title>
	<dc:creator>Nova, Hikmah</dc:creator>
	<dc:creator>Nita, Yunita</dc:creator>
	<dc:creator>Priyandani, Yuni</dc:creator>
	<dc:subject xml:lang="en-US">Cost of Illness</dc:subject>
	<dc:subject xml:lang="en-US">Disease Burden</dc:subject>
	<dc:subject xml:lang="en-US">TB</dc:subject>
	<dc:description xml:lang="en-US">Introduction: Tuberculosis (TB) remains a significant public health challenge in Indonesia, ranking among the highest global TB burden countries. The financial burden of TB is substantial, encompassing direct medical costs, indirect income losses, and catastrophic household expenditures. Although systematic reviews on TB-related cost-of-illness (COI) have been conducted in various settings, this study aims to fill critical gaps in Indonesian TB financial data, provide comparative regional insights, and offer actionable policy recommendations.
Methods: This study used the Systematic Review (SR) method on articles relevant to: COI, disease cost evaluation, or therapy costs for tuberculosis. Articles are examined in English or Indonesian; obtain full text through several search engines such as: PUBMED, Science Direct, Google Scholar, and SCOPUS; research coverage in Indonesia; and in an unlimited time frame.
Results: A total of 11 eligible articles were obtained based on inclusion and exclusion criteria. The direct cost of TB-DS ranges from Rp2.2-5.8 million, while TB-MDR reaches Rp190 million. Indirect costs due to loss of revenue reached Rp481.5 million for MDR-TB. Catastrophic costs occurred in 83% of TB-MDR households and 36% of TB-DS, exceeding 20% of annual income. Most patients were men of productive age (18-45 years), with 82.33% losing their jobs during treatment. These findings highlight the need for strategic interventions to reduce the economic impact of TB.
Conclusions: The impact of moderate financial burdens and other medical aspects on institutions and individuals is caused by tuberculosis. Further research should be conducted related to this study to obtain a larger estimate.</dc:description>
	<dc:publisher xml:lang="en-US">Pusat Pengembangan Teknologi Informasi dan Jurnal Universitas Muhammadiyah Palu</dc:publisher>
	<dc:date>2025-12-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jurnal.unismuhpalu.ac.id/index.php/jphp/article/view/6854</dc:identifier>
	<dc:identifier>10.56338/jphp.v6i1.6854</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Public Health and Pharmacy; Vol. 6 No. 1 (2026); 49-65</dc:source>
	<dc:source>2775-4952</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jurnal.unismuhpalu.ac.id/index.php/jphp/article/view/6854/6389</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2025 Journal of Public Health and Pharmacy</dc:rights>
</oai_dc:dc>